The latest price target for Dolby Laboratories (NYSE:DLB) was reported by Barrington Research on January 30, 2026. The analyst firm set a price target for $90.00 expecting DLB to rise to within 12 months (a possible 41.40% upside). 14 analyst firms have reported ratings in the last year.

The latest analyst rating for Dolby Laboratories (NYSE:DLB) was provided by Barrington Research, and Dolby Laboratories maintained their outperform rating.

The last upgrade for Dolby Laboratories Inc happened on June 3, 2024 when Barrington Research raised their price target to $100. Barrington Research previously had a market perform for Dolby Laboratories Inc.

There is no last downgrade for Dolby Laboratories.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Dolby Laboratories, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Dolby Laboratories was filed on January 30, 2026 so you should expect the next rating to be made available sometime around January 30, 2027.

While ratings are subjective and will change, the latest Dolby Laboratories (DLB) rating was a maintained with a price target of $90.00 to $90.00. The current price Dolby Laboratories (DLB) is trading at is $63.65, which is out of the analyst’s predicted range.